America’s Unsafe Medical Products

Print Email

DG/Health Naturals Baby Cough Syrup + Mucus
> Issue Date: March 20, 2019
> Type of alert: Recall

Kingston Pharma is recalling lot KL 180157 of this product because it may be contaminated with bacteria that can produce two forms of gastrointestinal illness with symptoms of vomiting or diarrhea. No illnesses have been reported to date.

Mylan Recalls Levoleucovorin Injection
> Issue date: March 18, 2019
> Type of alert: Recall

Mylan is voluntarily recalling two lots of its levoleucovorin 250 mg per 25 mL injection due to the presence of copper salts in the solution. The drug is used to treat cancer, among other things, and the salts found during stability testing could cause severe consequences, including pulmonary embolism.

Cook Medical Recalls Transseptal Needles
> Issue date: March 18, 2019
> Type of alert: Recall

Cook Medical is voluntarily recalling 97 transseptal needles used to access the left side of a patient’s heart during cardiac procedures. Due to a manufacturing flaw, the needle tips are missing the back bevel that creates a sharp tip. The recall was initiated by the company on February 1.

Hospira 8.4% Sodium Bicarbonate Injection
> Issue date: March 15, 2019
> Type of alert: Recall

Hospira, a division of Pfizer, is voluntarily recalling three lots of the sodium bicarbonate solution due to glass contamination. The solution is delivered intravenously to treat metabolic acidosis.


Treating Peripheral Arterial Disease With Paclitaxel-Coated Devices
> Issue date:

March 15, 2019
> Type of alert: Letter to health care providers

In a letter to health care providers on January 17, 2019, the FDA notified peripheral interventionists and vascular medicine physicians of a “possible increased mortality rate after two years” compared to patients treated with non-coated balloons or bare-metal stents. Further analysis of three trials now reveals a 50% increase in mortality risk in patients treated with paclitaxel-coated devices after five years.

Legacy Pharmaceutical Packaging 50 mg Losartan Tablets
> Issue date: March 15, 2019
> Type of alert: Recall

Three lots of 50 mg Losartan tablets used to treat high blood pressure were voluntarily recalled due to possible contamination of the medication manufactured by Hetero Labs.

American Health Packaging 160 mg Valsartan Tablets
> Issue date: March 8, 2019
> Type of alert: Recall

One lot of valsartan tablets manufactured by Aurobindo Pharma and distributed by American Health Packaging have been voluntarily recalled due to trace amounts of an unexpected impurity in the finished product that is classified as a possible human carcinogen. Valsartan is used to treat high blood pressure in some patients, who are advised by the FDA to continue taking their medicine because the risk to their health if they stop suddenly may be greater than the risk of taking the recalled medication. The lot number being recalled is 179791.